Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Diverse Trial Designs, Populations, and Outcomes: A Systematic Literature Review of Trials for the Treatment of Hereditary Angioedema Attacks.
Journal: Advances in therapy
Published: April 09, 2026
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment Comparison.
Journal: Advances in therapy
Published: March 05, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.
Journal: Advances in therapy
Published: February 23, 2026
Patient-reported disease burden and health care utilization of HAE-nl-C1INH: insights from a real-world survey.
Journal: Clinical and experimental medicine
Published: November 14, 2025
Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.
Journal: Clinical reviews in allergy & immunology
Published: November 05, 2025
A Randomized Dose-Finding Study of Anti-KIT Barzolvolimab in Patients with Chronic Spontaneous Urticaria.
Journal: The Journal of allergy and clinical immunology
Published: October 01, 2025
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: September 08, 2025
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: August 25, 2025
Reply to Zhang et al.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: June 02, 2025
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation.
Journal: The Journal of allergy and clinical immunology
Published: April 21, 2025
Omalizumab pretreatment in a case of pediatric carboplatin desensitization.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: March 25, 2025
Last Updated: 09/26/2026